Glucose utilization in vivo by human pulmonary neoplasms.
about
Understanding the Warburg effect: the metabolic requirements of cell proliferationThe sweet trap in tumors: aerobic glycolysis and potential targets for therapySuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and EpigeneticsWeight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.PET/CT in Oncology: Current Status and Perspectives.Pulmonary 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertensionEffects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports.PET-CT guided curative conformal radiation therapy in limited stage small cell lung cancerPositron emission tomography for tumour assessment.A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.The clinical significance of incidental intra-abdominal findings on positron emission tomography performed to investigate pulmonary nodules.Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acidThe role of positron emission tomography in the management of non-small cell lung cancer.Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancerUsefulness of additional delayed regional F-18 Fluorodeoxy-Glucose Positron Emission Tomography in the lymph node staging of Non-Small Cell Lung Cancer patients.Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography.Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.Age-dependent metabolic dysregulation in cancer and Alzheimer's disease.Positron emission tomography: theory and its application to the study of lung disease.History and future technical innovation in positron emission tomography.Metabolic alterations during the growth of tumour spheroids.Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime.Molecular imaging with PET--the future challenges.Positron emission tomography in oncology.Positron emission tomography scanning in cancer.18F-fluorodeoxyglucose PET scans in lung cancer.Modification of tumour glucose metabolism for therapeutic benefit.Metabolic substrate utilization by tumour and host tissues in cancer cachexiaDominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism.Current role of positron emission tomography in thoracic oncology.Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers.Tumour-associated hypoglycaemia in a murine cachexia model.Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomas.A statistical clustering approach to visualizing the relationship between early and delayed images in whole-body FDG-PET.Imaging with F-18 FDG PET is superior to Tl-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy.A prospective investigation of the prevalence and prognostic significance of weight loss and changes in body condition in feline cancer patients.The Glycolytic Switch in Tumors: How Many Players Are Involved?Non-Michaelis-Menten kinetics of zero-trans glucose uptake by trophoblast cells from human term placentae and by choriocarcinoma (JEG-3/JAR) cells.The Role of FDG-PET in the Preoperative Assessment of N-Staging in Head and Neck Cancer
P2860
Q24604760-6CDC7597-3911-440F-B3CF-C95793AAD745Q26766079-FCC58DCB-B718-4618-BE0E-6AF9EC548BF1Q26796203-5A3175A0-7A7D-408B-AABA-500EAD60496DQ30572730-DD0C0B0C-E948-456F-9349-C557C53EEBB3Q33534399-6DE03ACC-A97B-4ED6-BF58-1A2AA70CB27CQ33665109-DE1DD8DE-8FCF-40BC-B2AA-3F5CF7DFA77AQ33806143-7F2EE6ED-CCB7-4AD8-A65E-6AC8EAB34AFCQ34722625-D7AFF65A-9CCE-44EE-9E42-AC189FBD6B6AQ35290430-6E126F9F-745D-40E7-9365-54D49BD058F5Q35538318-195B38A5-508F-499A-9B70-8732F15C2E08Q35738991-58F98196-43C7-4A92-A092-2F048002878FQ35768761-99E38A62-8289-4E4C-805B-F75135C49E7EQ36618004-5A6B7656-AD99-474B-B5E2-EB4017064864Q37210598-1B8CBB25-6894-4BB1-9399-4D8E733A7033Q37378234-675E1A7F-DA64-424F-B6B2-8855A2D7549DQ37446915-C15AA65C-0901-4D59-AD55-EF243E97B775Q37643555-EF108179-C23E-4318-B2F4-12853AF83E50Q37746021-164A4E94-93CC-4FC3-A3FC-FB663EDD2FE9Q38259091-F4B92A3E-62DF-40B4-9D61-F5C4A4F6FD5EQ38607883-7F058F98-AA38-4C46-9411-AB6A3A32CD9FQ38731565-306D301F-A996-4093-A860-C86646B1B19DQ39095849-9403793C-564F-4587-BC39-C5F8C627639EQ40037417-32CB8699-BE6D-4F5F-B9D2-B1549634BAB4Q40611448-6580F7A0-E51D-497D-9183-014EE9DF254AQ40668959-94957A22-D4F0-4C80-A41F-739778F0993EQ40801115-01ED8E96-F1B1-4EEE-94FE-98B7845E4501Q41163212-BB03089D-A579-49A3-8D00-0FF3BBCB75B2Q41393231-2D07F901-3658-44D6-992C-D2BB71F725D5Q41674556-8C278AD3-0918-48DB-A4E1-21139050C7F1Q41857469-3D443A39-E251-462E-AFAD-6A840785E618Q42137075-B6D4967E-3F6D-4607-B9FA-0BCFEB23BA67Q42329676-F112E36B-D7D0-4DE9-9693-D38644C42C94Q42371328-4E052681-9EC8-4268-93F6-9C548650F3F7Q42382532-C1F00AB8-65A2-4EB9-9C23-8967353A26BBQ42915774-5B432653-A675-49E9-9173-5AAD158C8577Q43923140-2926D3A3-365C-4960-86F5-694E5D11480CQ45093842-15BC13AE-811A-4ECF-988D-E2629D8DC49EQ45419184-83C618C8-8A81-4526-ACD1-41A9BB568BD4Q52373606-A5F34590-C1BD-485B-9A74-BD4EF4C1871EQ58080229-1FD75591-8454-4EFE-99C3-59244A5E8346
P2860
Glucose utilization in vivo by human pulmonary neoplasms.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Glucose utilization in vivo by human pulmonary neoplasms.
@en
Glucose utilization in vivo by human pulmonary neoplasms.
@nl
type
label
Glucose utilization in vivo by human pulmonary neoplasms.
@en
Glucose utilization in vivo by human pulmonary neoplasms.
@nl
prefLabel
Glucose utilization in vivo by human pulmonary neoplasms.
@en
Glucose utilization in vivo by human pulmonary neoplasms.
@nl
P2093
P1433
P1476
Glucose utilization in vivo by human pulmonary neoplasms.
@en
P2093
P304
P356
10.1002/1097-0142(19871201)60:11<2682::AID-CNCR2820601118>3.0.CO;2-H
P407
P50
P577
1987-12-01T00:00:00Z